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Abstract
Purpose Restorative proctocolectomy is a current gold stan-
dard procedure for patients who require a colectomy for ulcer-
ative colitis. The incidence of ileal pouch neoplasia is low. The
aims of this study were to assess the prevalence of neoplasia in
ileal pouch and investigate the risk factors for ileal pouch
neoplasia.
Methods A total of 276 patients who underwent restorative
proctocolectomy for ulcerative colitis between 1984 and
2009 were analyzed. Results of histological examinations of
both original specimen and biopsies from the J-pouch taken
during routine pouch endoscopy were evaluated. Patients’ re-
cords were analyzed for ulcerative colitis duration, the time
from pouch creation to pouch neoplasia, presence of
pouchitis, as well as the concurrent primary sclerosing
cholangitis.
Results Analyzing the original specimen of large bowel, fifty-
six lesions of low-grade dysplasia, twenty-five high-grade
dysplasia, and five adenocarcinoma were revealed. All pa-
tients with dysplasia (n=8) or adenocarcinoma (n=1) of the
J-pouch were positive for dysplasia in the original specimen.
Duration of ulcerative colitis before surgery and duration time
following restorative proctocolectomy were found as risk fac-
tors for J-pouch neoplasia with a significant difference (p=
0.01 and p=0.0003, respectively). Patients with pouch neo-
plasia developed significantly more severe pouchitis (p=
0.00001).
Conclusions Neoplasia of the J-pouch is rare. Patients with
neoplasia in the original specimen are more susceptible to
develop neoplasia in the J-pouch. Precise follow-up in patients
with neoplasia lesions in the original specimen should be rec-
ommended. Moreover, in patients with risk factors, the exact
surveillance pouch endoscopy should be recommended.
Keywords Restorative proctocolectomy . Ileal pouch .
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Introduction
Restorative proctocolectomy (RPC) with ileal pouch-anal
anastomosis (IPAA) is a current gold standard procedure for
ulcerative colitis (UC) patients who required surgical
treatment.
Ulcerative colitis is a well-known risk factor for colorectal
cancer (CRC). The presence of dysplasia as well as adenocar-
cinoma of the large bowel mucosa constitute the indications
for surgical management [1]. It was also proven that the pres-
ence of CRC in the original specimen increases the risk of ileal
pouch dysplasia [2, 3].
In general, the prevalence of dysplasia and adenocarcino-
ma in the ileal pouch is low. The cumulative incidence of ileal
pouch neoplasia (both dysplasia and cancer) at 10 and 20 years
in UC patients following RPCwas 1.3 and 4.2 %, respectively
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[3]. Comparable results were presented by Derikx et al. show-
ing the cumulative incidence of pouch neoplasia at 10 and
20 years after pouch creation to be 2.0 and 6.9 %, respectively
[1]. However, the incidence of ileal pouch neoplasia is signif-
icantly higher in the group of patients with colorectal neopla-
sia in the original specimen [1].
Although many potential risk factors have been investigat-
ed so far, only some have been identified as a significant risk
factor for ileal pouch neoplasia. Pouchitis, prior colorectal
cancer, time of UC duration before RPC, concurrent primary
sclerosing cholangitis (PSC), and type of IPAA (presence of
mucosectomy) were the most common indicated as reported
risk factors [3–7].
The first case report of pouch dysplasia was reported in
1991 [8]. Since then, there were plenty of publications regard-
ing dysplasia and adenocarcinoma of the ileal pouch follow-
ing RPC. In 2007, Scarpa et al. reported 22 cases of adeno-
carcinoma in pouch diagnosed worldwide, whereas 4 years
later, Liu et al. presented 42 cases [7, 9]. It is believed that
the longer follow-up in the group of patients after RPC is
achieved, the more studies regarding ileal pouch neoplasia
will be presented.
In the recent study, we proved that pouchitis may increase
the risk of J-pouch dysplasia following RPC for UC patients
[4]. The main goals of the present study were to assess the
prevalence of neoplasia of the ileal pouch in UC patients who
underwent RPC and analyze the potential risk factors for
pouch neoplasia. We also investigated if there was any corre-
lation with pouch neoplasia in patients with prior neoplasia in
the original specimen of large bowel.
Material and methods
The study was approved by the institutional bioethics commit-
tee at Poznan University of Medical Sciences.
Retrospectively, we analyzed a group of 298 patients who
underwent RPC for UC in our institution between 1985 and
2009. Exclusion criteria were patients diagnosed with Crohn’s
disease based on the final histopathological examination.
Finally, 276 patients were included into the study. Data was
collected based on the available medical records. Patients’
records were analyzed for sex, age, duration of UC before
RPC, duration from pouch creation to pouch dysplasia, tech-
nique of IPAA anastomosis, presence of pouchitis, and
pouchitis disease activity index (PDAI) score as well as the
concurrent PSC.
RPC was performed in a standard manner. In our institu-
tion, only the J type of pouch configuration was performed.
The first 27 procedures were performed with hand-sewn
IPAA. In remaining patients, stapled IPAA was carried out.
Depending on variety of factors (comorbidities, steroid
regimen, urgent surgery, and others), two- or three-stage
RPC was performed (Table 1).
Retrospectively, histopathological examination of the large
bowel in all patients was evaluated. Routinely, the original
specimen was prepared in the standard manner (intestine con-
tents were flushed out and specimen was secured with 10 %
buffered formalin) and sent for histopathological examination.
Analysis was carried out regarding no neoplasia, CRC, or
dysplasia (low-grade dysplasia (LGD) or high-grade dysplasia
(HGD)) of mucosal large bowel.
Clinical examination and endoscopy of the pouch with bi-
opsy performed yearly were routinely practiced as an institu-
tional standard follow-up in UC patients following RPC.
Pouch endoscopy was performed usually in the Pouch
Outpatient Clinic with the usage of a rectoscope of various
sizes (8 or 15 mm in diameter) depending on the IPAA diam-
eter established during per rectum examination. It was per-
formed by one of four surgeons who were well-experienced
in endoscopy. Routinely, multiple biopsies were taken from
(1) the body of the pouch and (2) IPAA. Additional biopsy
was taken from each suspected mucosa within the ileal pouch.
Routinely, we did not take biopsy of the anal transition zone
(ATZ) unless there were any macroscopic changes.
Histopathological examination was performed by a gastroin-
testinal pathologist and approved by a second pathologist.
We analyzed and performed statistical examinations of 846
biopsies performed from 2004 to 2009. Most of the examina-
tions were performed in our center, andwe included data regard-
ing 24 endoscopic examinations from other outside centers.
Pouchitis was diagnosed based on PDAI when at least 7
points was achieved. Chronic pouchitis was diagnosed in pa-
tients in whom at least three episodes of pouchitis were diag-
nosed within 12 consecutive months and at least in the course
of one episode pouchitis was confirmed during an endoscopic
examination with biopsy [10].
The analyzed results were presented as an average±stan-
dard deviation. As part of the statistical examination, patients
were divided into two groups: patients with pouch neoplasia
(n=9) and patients without diagnosed foci of neoplasia in the
pouch (267 patients). Chi-square test (Pearson’s test) was per-
formed to confirm the correlations between certain character-
istics such as the presence of pouch neoplasia and dysplasia or
neoplasia in the large intestine before RPC, duration of UC
before RPC, and intensity of PDAI. Statistically significant
Table 1 Characteristics of surgical management in UC patients
qualified for RPC
Type of surgery Elective Urgent Total
Two-stage surgery 178 28 206
Three-stage surgery 6 64 70
Total 184 92 276
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results were those with a p value <0.05. All the statistical
analyses were performed using Statistica 10 (StatSoft, Inc.,
Tulsa, USA).
Results
The study group comprised of 127 women (46.1 %) and 149
men (53.9%). Themean age at the time of surgerywas 43.2 years
(SD 11.9). The mean time of UC duration before RPC was
11.5 years (SD 6.1; range 1–33 years), whereas the mean time
of follow-up was 9.8 years (SD 6.1; range 1–23 years).
Based on the histopathological examinations of the original
specimen of the large bowel, 56 patients with low-grade dys-
plasia and 25 patients with high-grade dysplasia were diag-
nosed. In five (n=5) patients, adenocarcinoma of the large
bowel was revealed. In the remaining samples (n=190) of
the original specimen of the large bowel, there was neither
dysplasia nor adenocarcinoma.
Based on the available medical records, we analyzed the
results of biopsies taken during routine J-pouch endoscopy.
Patients’ characteristics with dysplasia and adenocarcinoma
of the ileal pouch are displayed in Table 2. In five patients
(n=5), LGD was revealed; in three patients (n=3), HGD was
diagnosed; whereas in one patient (n=1), adenocarcinoma
was confirmed. The analyzed group of patients with J-pouch
neoplasia consisted of five males (n=5) and four females (n=
4). All reported patients with J-pouch neoplasia were positive
for neoplasia in the original specimen of the large bowel
(Fig. 1). The prevalence of both dysplasia and colorectal can-
cer in the original specimen had a significant influence on J-
pouch neoplasia (p=0.00001). Patients diagnosed with either
pouch adenocarcinoma (n=1) or HGD (n=3) were qualified
for pouch excision. In two patients with LGD, pouch excision
was performed as well: one patient with concomitant severe
pouchitis refractory to conservative treatment and in the sec-
ond one because of concomitant pouch dysfunction.
Remaining patients were qualified for endoscopic excision
without any further repercussion. Mostly in the group of pa-
tients treated with an endoscopic approach, polypoid lesions
were diagnosed. All patients diagnosed with neoplasia and
treated either surgically or endoscopically required close
follow-up (every 3–6 months).
Duration of ulcerative colitis before RPC was revealed as a
significant risk factor for pouch neoplasia (p=0.01). Themean
duration of UC before RPC in the group of ileal pouch neo-
plasia was 23 (SD 4.6), 20 (SD 1), and 21 years, respectively,
for LGD, HGD, and adenocarcinoma.
The mean age at the time of pouch construction in the group
of patients diagnosed with neoplasia was 40.9 (SD 3.6; range
36–47). There was no significant difference in the mean age
between groups with LGD, HGD, and adenocarcinoma: 41.8
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Patients with pouch neoplasia developed significantly
more severe pouchitis (expressed in PDAI scale) than patients
without neoplastic changes of ileal pouch mucosa (p=
0.00001). In the group of pouch neoplasia, the mean PDAI
score was 8.8 (SD 1.6), 9.7 (SD 0.6), and 11 for patients with
ileal pouch LGD, HGD, and adenocarcinoma, respectively.
Duration from pouch creation to pouch neoplasia was sig-
nificantly longer in patients with ileal pouch neoplasia than in
patients without pouch neoplasia (p=0.0003). The more se-
vere pouch neoplasia (LGD, HGD, and adenocarcinoma) was
revealed, the longer the time following RPC was assessed.
Neoplasia was revealed 13.6 (SD 4.6), 17.3 (SD 3.1), and
20 years after RPC for patients with ileal pouch LGD, HGD,
and adenocarcinoma, respectively.
Discussion
It was 1978 when Parks and Nicholls proposed RPC as a new
surgical technique to keep the gastrointestinal tract continued
in UC patients who required colectomy [11]. Up to date, a
total of 42 adenocarcinomas of the ileal pouch have been
reported [7]. Based on the review of literature regarding the
incidence of pouch cancer, the topographic localization of the
neoplasia was as follows: ATZ in 27 cases, pouch body in 8,
both ATZ and pouch body in 2, afferent limb in 1, and remain-
ing 4 locations were indefinite [7]. Surprisingly, based on our
study, in all except two patients (data was not available) did
we find pouch body as the most common topographic locali-
zation of the neoplasia following RPC.
Introduction of the stapled technique for IPAA allowed for
lower perioperative complication rates as well as functional
disorders of the neo-rectum resulting in anal canal sensations
or sphincter disturbances [12]. However, it has raised the con-
troversy whether leaving the mucosa of the ATZ may predis-
pose to pouch neoplasia. According to current studies, 24 of
42 patients (57.1 %) developed pouch adenocarcinoma fol-
lowing hand-sewn IPAA [7]. The possible explanation of the
fact is the remnant of a large-bowel mucosal islet following
the mucosectomy [4]. The firm conclusion regarding the in-
fluence of the IPAA technique on ileal pouch neoplasia should
not be drawn based on this study. Only the first 27 patients
were operated with hand-sewn anastomosis, and in the major-
ity of cases (n=6/9), stapled IPAAwas performed. However,
in three patients with hand-sewn IPAA (and mucosectomy),
pouch neoplasia developed.
Fig. 1 Flowchart of ileal pouch
neoplasia patients with positive
neoplasia lesions in the original
specimen of the large bowel
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It was proven that secondary bile acids may contribute to
the increased risk of neoplasia in patients with UC and con-
comitant PSC [13]. Stahlberg et al. presented the relationship
between the incidence of mucosal atrophy of the ileal pouch
and concomitant PSC [14]. However, based on the data from
Cleveland Clinic, none of the patients diagnosed with pouch
adenocarcinoma suffered from PSC [2]. Because of some
missing data regarding concurrent PSC in the pouch neoplasia
group, we did not analyze this factor; thus, the exact conclu-
sion should not be drawn.
Pouchitis is the most common complication of the pouch in
UC patients following RPC [15]. The prevalence of pouchitis
is estimated to be up to 50% in patients after RPC for UC [16].
Chronic pouch inflammation was stated to be a risk factor for
pouch neoplasia [4, 17]. It was suggested that the chronic
pouchitis may predispose to atrophy of the mucosa resulting
in possible dysplasia [17]. Moreover, patients who developed
type C villous atrophy were more susceptible to malignancy
than type A or B [18]. In the latest large studies presented by
Kariv et al. and Derikx et al. based on 3203 and 1200 patients,
respectively, pouchitis was not found to be an independent
risk factor for neoplasia [1, 2]. However, chronic pouchitis
was revealed in 3 of 11 patients (27.3 %) diagnosed with
pouch adenocarcinoma [2]. Based on our histopathological
examination, pouchitis was found to be a risk factor predis-
posing for neoplasia of the pouch. In all except one patient
(LGD of the ileal pouch), the histopathological examination
revealed inflammation of the pouch. The mean PDAI in the
group of patients without neoplasia was significantly lower
than in groups with neoplasia of the pouch.
Both dysplasia and colorectal cancer in the original speci-
men of the large bowel at the time of RPCwere risk factors for
developing neoplasia of the ileal pouch [3, 19]. Although the
underlying pathology of molecular defects of DNA repair
mechanisms in UC patients has been proposed, the exact pat-
tern of the disturbances is still unknown [20, 21]. Analysis of
42 patients with pouch adenocarcinoma revealed that 24 of
them (57%) had been diagnosed with colorectal cancer before
or at the time of pouch creation [7]. In the present study, in all
patients who developed either pouch dysplasia or adenocarci-
noma, the original specimen was positive for neoplasia.
Branco et al. found that the duration of UC before RPC in
the group of patients with pouch cancer was longer than those
without neoplasia (20.3 vs 11.2 years) [22]. These results are
consistent with the ones presented in our study. The mean
duration of IBD before RPC was significantly longer in the
groups with pouch neoplasia than in patients without pouch
neoplasia (20.2 vs 11.2 years).
Pouch endoscopy is a current gold standard investigation
for follow-up in patients following RPC. However, the suc-
cess rate in detecting dysplastic lesions of the pouch is still
low. In the analyzed data of 42 patients with diagnosed ade-
nocarcinoma of the pouch, in 23 of them, any neoplastic
lesions were found before the final diagnosis of adenocarci-
noma was revealed [7]. According to our results, there is a
significant correlation between the presence of dysplastic
changes and CRC in the original specimen of the large bowel
and neoplastic lesions in the pouch. Further studies and obser-
vations are necessary to evaluate the benefits of such protocol.
The natural history of pouch neoplasia is still a topic that
has not been fully examined yet. Despite the fact that potential
risk factors for the development of pouch neoplasia have been
defined, the precise protocol regarding the care of patients
after RPC is still a topic of discussion. It has been established
that there is a low incidence of pouch neoplasia. Although,
some authors questioned the necessity of performing pouch
endoscopy as surveillance, in our opinion, such surveillance
should be recommended [23, 24]. Regular pouch endoscopy
surveillance, especially among high-risk patients (prior colo-
rectal cancer, pouchitis), seems to be a necessary element in
the early diagnosis of pouch neoplasia. Moreover, in patients
with a long duration of UC before RPC aswell as in those with
long-term follow-up after RPC, the exact surveillance pouch
endoscopy should be recommended.
Based on the analyzed results in this study, it is still a
question whether pouch endoscopy surveillance in the group
of patients with prior colorectal neoplasia should be per-
formed more often. The significant correlation between prior
colorectal neoplasia and pouch neoplasia allows to think that
the correlation is strong and associated with a high risk of
pouch neoplasia.
We would like to emphasize the necessity for prophylaxis
for chronic pouchitis which is a trigger for pouch neoplasia.
All patients in the group with pouch neoplasia except one had
a high correlation between the presence of pouchitis and the
presence of pouch neoplasia, strongly suggesting initiation of
a long-term prophylaxis and treatment for chronic pouchitis
[25].
It should be noted that the final pathological diagnosis re-
garding hyperplastic and reactive adaptive changes as well as
pouchitis and low-grade dysplasia may be easily confused.
Thus, it is recommended to assess the histopathological spec-
imen by at least two pathologists [26].
There are some limitations of the study. Routinely, we did not
perform multifocal biopsies of the ATZ unless any suspected
macroscopic lesions were revealed. As a standard in our
Institution,we routinely took samples from the body of the pouch
and IPAA. However, based on the study presented by
Thompson-Fawcett et al., multifocal biopsy was not found as
necessary in patients following RPC and UC within a duration
of 10 years [27]. Moreover, it was proven in pooled published
cases that the mean interval from RPC to cancer within the ATZ
was 23 years whereas in the pouch body 11 years [7]. Based on
our experience, we are in line with the statements that the accu-
rate grading of J-pouch neoplasia is difficult. However, taking
multifocal biopsies and evaluating samples by two independent
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pathologists, thus, we believe to have the accurate results opti-
mized. From a practical point of view, it is important to analyze if
there is any correlation between the prevalence of J-pouch neo-
plasia in groups of patients qualified for RPC because of neopla-
sia of the large bowel versus refractory ulcerative colitis whatwill
be the subject of further analysis.
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